FI963696A - Geeli ihosairauksien hoitoon ja ihon desinfiointiin - Google Patents

Geeli ihosairauksien hoitoon ja ihon desinfiointiin Download PDF

Info

Publication number
FI963696A
FI963696A FI963696A FI963696A FI963696A FI 963696 A FI963696 A FI 963696A FI 963696 A FI963696 A FI 963696A FI 963696 A FI963696 A FI 963696A FI 963696 A FI963696 A FI 963696A
Authority
FI
Finland
Prior art keywords
skin
gel
alcohol
disinfection
gives
Prior art date
Application number
FI963696A
Other languages
English (en)
Swedish (sv)
Other versions
FI963696A0 (fi
Inventor
Thomsen John Brown
Jens Christian Moeller
Original Assignee
Thomsen John Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomsen John Brown filed Critical Thomsen John Brown
Publication of FI963696A0 publication Critical patent/FI963696A0/fi
Publication of FI963696A publication Critical patent/FI963696A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FI963696A 1994-03-21 1996-09-18 Geeli ihosairauksien hoitoon ja ihon desinfiointiin FI963696A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32594 1994-03-21
PCT/EP1995/001025 WO1995025544A1 (en) 1994-03-21 1995-03-20 Gel for treatment of skin diseases and for disinfection of the skin

Publications (2)

Publication Number Publication Date
FI963696A0 FI963696A0 (fi) 1996-09-18
FI963696A true FI963696A (fi) 1996-11-07

Family

ID=8092278

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963696A FI963696A (fi) 1994-03-21 1996-09-18 Geeli ihosairauksien hoitoon ja ihon desinfiointiin

Country Status (26)

Country Link
US (4) US5981605A (fi)
EP (1) EP0751789B1 (fi)
JP (1) JP3560977B2 (fi)
KR (1) KR100396278B1 (fi)
CN (1) CN1146725A (fi)
AT (1) ATE208212T1 (fi)
AU (1) AU701872B2 (fi)
BR (1) BR9507164A (fi)
CA (1) CA2186045A1 (fi)
CZ (2) CZ286758B6 (fi)
DE (1) DE69523745T2 (fi)
DK (1) DK0751789T3 (fi)
EE (1) EE03293B1 (fi)
ES (1) ES2168111T3 (fi)
FI (1) FI963696A (fi)
HU (1) HUP9774641A2 (fi)
LV (1) LV12951B (fi)
MX (1) MX9604208A (fi)
NO (1) NO314126B1 (fi)
NZ (1) NZ283135A (fi)
PL (1) PL179918B1 (fi)
PT (1) PT751789E (fi)
RU (1) RU2142273C1 (fi)
SK (1) SK281575B6 (fi)
UA (1) UA41989C2 (fi)
WO (1) WO1995025544A1 (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ286758B6 (en) * 1994-03-21 2000-06-14 Thomsen John Brown Pharmaceutical preparation in the form of a gel for treating skin diseases
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
DE19624508A1 (de) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Verwendung von C¶3¶-C¶4¶-Alkoholen zur Behandlung von Herpeserkrankungen
CA2265774C (en) 1996-06-24 2009-05-05 Bio-Safe Enterprises, Inc. Antibacterial composition
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
EP1295893A4 (en) * 2000-05-31 2005-10-26 Japan Science & Tech Agency GINSENOSIDES FOR PROMOTING SKIN WEBERENEGENERATION
AUPR028000A0 (en) * 2000-09-21 2000-10-12 Hair Advisory Centre Pty. Ltd. Ectoparasite formulation
US6581775B1 (en) * 2001-08-10 2003-06-24 Garo Hagopian Method of external genital cleansing and prophylactic kit
EA200400535A1 (ru) * 2001-10-16 2005-06-30 Аванир Фармасютикалз ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
US20040191286A1 (en) * 2003-03-24 2004-09-30 Bijan Safai Head lice medication and treatment
GB0318160D0 (en) * 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
DE102005059742A1 (de) 2005-12-13 2007-06-14 Beiersdorf Ag Transparentes Sonnenschutzmittel
DK2054031T3 (en) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmucosal delivery devices with improved uptake
BRPI0622061B8 (pt) 2006-10-23 2021-05-25 Ecolab Inc composição viricida, uso e produto compreendendo a mesma
JP2010511723A (ja) * 2006-12-04 2010-04-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 局所医薬組成物
JP5028131B2 (ja) * 2007-04-13 2012-09-19 花王株式会社 ゲル化剤
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US20100247564A1 (en) * 2007-05-24 2010-09-30 David Yue-Wei Lee Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
DE102008028993A1 (de) * 2007-06-29 2009-01-08 Bode Chemie Gmbh & Co. Kg Verwendung eines alkoholischen Desinfektionsmittels zur Schnelldesinfektion
EA013233B1 (ru) * 2008-06-12 2010-04-30 Иностранное Частное Унитарное Производственно-Торговое Предприятие "Инкраслав" Фирмы "Вера, О.О.О. Прешов" Антисептическая композиция для дезинфекции кожных покровов, способ ее приготовления и полупродукт для ее приготовления
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2512231B1 (en) * 2009-12-16 2016-12-07 Ecolab Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
GB201010256D0 (en) * 2010-06-18 2010-07-21 Reckitt Benckiser Inc Germicidal topical compositions
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US10071233B2 (en) * 2015-05-22 2018-09-11 L'oreal Point applicator for treating skin conditions
US10334853B2 (en) * 2016-03-29 2019-07-02 Larada Sciences Compositions and methods for treating ectoparasite infestation
EP4048237B1 (en) * 2019-10-25 2024-02-28 Mucocort AB Treatment of inflammatory condition in mucous membrane or skin with low amounts of propylene glycol

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
DE1000367B (de) 1952-11-17 1957-01-10 Mo Och Domsjoe Ab Verfahren zur Herstellung von in Wasser und/oder Alkali loeslichen Celluloseaethern
US3016328A (en) * 1961-01-03 1962-01-09 Ethicon Inc Dialdehyde alcoholic sporicidal composition
US4019521A (en) * 1973-06-06 1977-04-26 Philip Morris Incorporated Smokable material and method for preparing same
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
US4256872A (en) * 1978-09-26 1981-03-17 Occidental Research Corporation Process for preparing layered organophosphorus inorganic polymers
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4590214A (en) * 1980-04-14 1986-05-20 Sepreh, Inc. Method of treatment for herpes
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4431633A (en) * 1982-04-27 1984-02-14 Merck & Co., Inc. Influenza vaccine
DE3430709A1 (de) * 1984-08-21 1986-03-06 Krüger GmbH & Co KG, 5060 Bergisch Gladbach Viruzides mittel
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
FR2613621B1 (fr) * 1987-04-10 1990-06-29 Roussel Uclaf Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
AU653248B2 (en) * 1991-06-20 1994-09-22 Cep Holdings, Inc. Topical composition enhancing healing of herpes lesions
US5376366A (en) 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
CZ286758B6 (en) * 1994-03-21 2000-06-14 Thomsen John Brown Pharmaceutical preparation in the form of a gel for treating skin diseases
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
HU9602583D0 (en) 1996-11-28
CZ286758B6 (en) 2000-06-14
FI963696A0 (fi) 1996-09-18
WO1995025544A1 (en) 1995-09-28
US5981605A (en) 1999-11-09
UA41989C2 (uk) 2001-10-15
DK0751789T3 (da) 2003-09-08
PL316651A1 (en) 1997-02-03
PL179918B1 (pl) 2000-11-30
BR9507164A (pt) 1997-09-09
RU2142273C1 (ru) 1999-12-10
HUP9774641A2 (en) 1997-01-28
EE03293B1 (et) 2000-10-16
ATE208212T1 (de) 2001-11-15
AU701872B2 (en) 1999-02-11
EP0751789B1 (en) 2001-11-07
EP0751789A1 (en) 1997-01-08
CZ288150B6 (en) 2001-05-16
DE69523745T2 (de) 2002-08-08
US20020086905A1 (en) 2002-07-04
CA2186045A1 (en) 1995-09-28
MX9604208A (es) 1998-05-31
SK119496A3 (en) 1997-06-04
NO963971L (no) 1996-11-19
SK281575B6 (sk) 2001-05-10
NZ283135A (en) 2004-12-24
ES2168111T3 (es) 2002-06-01
NO963971D0 (no) 1996-09-20
CN1146725A (zh) 1997-04-02
DE69523745D1 (de) 2001-12-13
LV12951B (en) 2003-05-20
PT751789E (pt) 2002-04-29
US20040054015A1 (en) 2004-03-18
US6342537B1 (en) 2002-01-29
KR100396278B1 (ko) 2003-11-28
NO314126B1 (no) 2003-02-03
JPH09510468A (ja) 1997-10-21
AU2109995A (en) 1995-10-09
JP3560977B2 (ja) 2004-09-02
CZ272396A3 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
FI963696A0 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
MY119403A (en) Novel compounds with analgesic effect.
MY132705A (en) Novel compounds with analgesic effect
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
SE9504661D0 (sv) New compounds
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
FI963687A (fi) Hygieeniset ja kosmeettiset valmisteet ihosairauksien estämiseksi ja hoitamiseksi sekä menetelmä niiden valmistamiseksi
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE122008000004I1 (de) Formulierung zur peptidfreisetzung
SE9504662D0 (sv) New compounds
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
SE9403905D0 (sv) New formulations
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
HUP9800715A2 (hu) Seb- és nyálkahártya-antiszeptikum
MX9709530A (es) Uso de bis-1,2.4-triazoles para la manufactura de un medicamento para el tratamiento de canceres.
ITPD920102A0 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche,ferite e ustioni e come agente emostatico
NO20082299L (no) Anvendelse av et pleuromutilinderivat innen veterinaermedisin samt fremgangsmate for fremstilling av et medikament omfattende forbindelsen
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом

Legal Events

Date Code Title Description
MA Patent expired